/People

Eileen Carry, PhD

Founder

Founder at Zena Therapeutics

North Brunswick, New Jersey, United States

FoundedZena Therapeutics

Find your path to Eileen

120 people in our graph share verified history with Eileen — schools, employers, funds. One of them is your warm intro.

About

Eileen Carry, PhD, is a medicinal chemist and the founder and Chief Scientific Officer of Zena Therapeutics Inc., which is developing alternatives to benzodiazepines for acute anxiety and substance withdrawal in individuals at high risk of overdose. Her doctoral research at Rutgers identified partial GABA-A receptor positive allosteric modulators with nanomolar potency and a ceiling effect on respiratory depression. As CSO, she has led the company's preclinical development and secured NIH/NIDA funding and exclusive patent rights, drawing on more than eight years in drug discovery.

Founder at Zena Therapeutics

Intro paths

→

In turn, Eileen can intro founders to Zena Therapeutics's investors below.

Co-founders at Zena Therapeutics

ECEileen Carry
Eileen CarryChief Scientific Officer | co-Founder
AVAriane Vasilatis
Ariane VasilatisChief Executive Officer | co-Founder

Experience

  1. Zena Therapeutics Inc.Chief Scientific Officercurrent2023 — presentPrinceton, New Jersey, United States
  2. Zena Therapeutics Inc.Chief Scientific Officercurrent2022 — presentPrinceton, New Jersey, United States
  3. Rutgers UniversityResearch Scientist2021 — 2025
  4. Rutgers UniversityPrincipal Investigator NJHF Innovation Grant2019 — 2022New Brunswick, New Jersey, United States
  5. Rutgers UniversityGraduate Research Associate2015 — 2021
  6. The National Institute on Drug Abuse (NIDA)Start an SUD Start-up Challenge Team Leader2022
  7. National Science Foundation (NSF)Co-entrepreneurial Lead NSF-funded National Innovation Corps (ICorps)2022

Skills & more

Medicinal Chemistry

From Eileen's professional profile.

Frequently asked questions

Who is Eileen Carry, PhD?
Eileen Carry, PhD, is a medicinal chemist and the founder and Chief Scientific Officer of Zena Therapeutics Inc., which is developing alternatives to benzodiazepines for acute anxiety and substance withdrawal in individuals at high risk of overdose. Her doctoral research at Rutgers identified partial GABA-A receptor positive allosteric modulators with nanomolar potency and a ceiling effect on respiratory depression. As CSO, she has led the company's preclinical development and secured NIH/NIDA funding and exclusive patent rights, drawing on more than eight years in drug discovery.
Where does Eileen Carry, PhD work?
Eileen Carry, PhD is Founder of Zena Therapeutics.
What companies did Eileen Carry, PhD found?
Eileen Carry, PhD founded Zena Therapeutics.
Where did Eileen Carry, PhD go to school?
Eileen Carry, PhD studied at Rutgers University (Doctor of Philosophy - PhD, Medicinal Chemistry).

Founder mafias

Same school

Shared employers